{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:10:16Z","timestamp":1780107016966,"version":"3.54.0"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,8,15]]},"DOI":"10.2169\/internalmedicine.0474-22","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T22:10:13Z","timestamp":1673475013000},"page":"2413-2414","source":"Crossref","is-referenced-by-count":4,"title":["Two Elderly Men with Myasthenia Gravis during Androgen Deprivation Therapy for Prostate Cancer"],"prefix":"10.2169","volume":"62","author":[{"given":"Kazo","family":"Kanazawa","sequence":"first","affiliation":[{"name":"Department of Neurology, Juntendo University, School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Tomizawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Juntendo University, School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatou","family":"Iseki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Juntendo University, School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Juntendo University, School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Neurology, Juntendo University, School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gubbels Bupp MR, Jorgensen TN. Androgen-induced immunosuppression. Front Immunol 9: 794, 2018.","DOI":"10.3389\/fimmu.2018.00794"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yang DD, Krasnova A, Nead KT, et al. Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer. Ann Oncol 29: 386-391, 2018.","DOI":"10.1093\/annonc\/mdx744"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol 10: 46, 2010.","DOI":"10.1186\/1471-2377-10-46"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Jaretzki A, 3rd, Barohn RJ, Ernstoff RM, et al.; Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Myasthenia gravis: recommendations for clinical research standards. Neurology 55: 16-23, 2000.","DOI":"10.1212\/WNL.55.1.16"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology 52: 1487-1489, 1999.","DOI":"10.1212\/WNL.52.7.1487"},{"key":"6","unstructured":"6. Duan RS, Link H, Xiao BG. Dehydroepiandrosterone therapy ameliorates experimental autoimmune myasthenia gravis in Lewis rats. J Clin Immunol 23: 100-106, 2003."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pakpoor J, Goldacre R, Goldacre MJ. Low testosterone and myasthenia gravis in males: a national record-linkage study. J Neurol 263: 2547-2548, 2016.","DOI":"10.1007\/s00415-016-8319-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Steinberg AD, Roths JB, Murphy ED, Steinberg RT, Raveche ES. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL\/Mp-lpr\/lpr mice. J Immunol 125: 871-873, 1980.","DOI":"10.4049\/jimmunol.125.2.871"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhu ML, Bakhru P, Conley B, et al. Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator. Nat Commun 7: 11350, 2016.","DOI":"10.1038\/ncomms11350"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sutherland JS, Goldberg GL, Hammett MV, et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 175: 2741-2753, 2005.","DOI":"10.4049\/jimmunol.175.4.2741"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vermeulen A, Rubens R, Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab 34: 730-735, 1972.","DOI":"10.1210\/jcem-34-4-730"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gamat M, McNeel DG. Androgen deprivation and immunotherapy for the treatment of prostate cancer. Endocr Relat Cancer 24: T297-T310, 2017.","DOI":"10.1530\/ERC-17-0145"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/16\/62_0474-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:21:18Z","timestamp":1692415278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/16\/62_0474-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":12,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0474-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"article-number":"0474-22"}}